¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transport piece"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facilitated transport
    ÃËÁø¿î¹Ý
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum tubular transport
    ÃÖ°í¿ä¼¼°üÀ̵¿Ä¡
  • membrane transport
    ¸·¿î¹Ý
  • transport medium
    ¿î¹Ý¹èÁö
  • net transport
    ¼ø¿î¹Ý
  • transport number
    À̵¿ºÐÀ²
  • passive transport
    ¼öµ¿¿î¹Ý
  • supersonic transport
    ÃÊÀ½ÆÄ¼ö¼Û
  • transport
    ¿î¹Ý
  • transcapillary transport
    ¸ð¼¼°ü¿î¹Ý
  • transmembrane transport
    ¸·¿î¹Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • principal piece
    À¸¶äºÎºÐ
  • secretory piece
    ºÐºñÁ¶°¢
  • two piece crown
    ºÀ¼º±Ý°ü(Üîà÷ÐÝή).
  • two-piece lens
    ÀÌü¼º·»Áî
  • active transport
    ´Éµ¿(Àû)¿î¹Ý(¡­îÜê¡Úæ), ´Éµ¿(Àû)¼ö¼Û(ÒöÔÑîÜâÃáê)
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý(ê¡Úæ)(À̵¿,¼ö¼Û)
  • carrier mediated transport
    ¿î¹Ýü¸Å°³ À̵¿
  • catalysed transport
    Ã˸żö¼Û.
  • co-transport = symport
    °øµ¿¿î¹Ý(À̵¿, ¼ö¼Û)(ÍìÔÒê¡Úæ)
  • component, T (transport)
    T¼ººÐ, ¼ö¼Û¼ººÐ
  • counter transport
    ¿ª¹æÇâ(æ½Û°ú¾)°øµ¿¿î¹Ý(À̵¿, ¼ö¼Û)
  • diffusion-limited transport
    È®»êÁ¦ÇѼö¼Û
  • downhill transport =passive t.
    Çǵ¿¿î¹Ý(ù¬ÔÑê¡Úæ).
  • facilitated transport
    ÃËÁø¼ö¼Û(¡­âÃáê).
  • gas transport
    °¡½º¿î¹Ý(ê¡Úæ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • illicit transport
    ¹Ð¼ö¼Û(ÚËâÃáê)
  • intracellular transport
    ¼¼Æ÷³» ¼ö¼Û(á¬øàÒ®âÃáê)
  • mediated transport
    ¸Å°³¼ö¼Û(ØÚË¿âÃáê)
  • membrane transport
    ¸·À̵¿(دì¹ÔÑ)
  • nonmediated transport
    ºñ(Þª)¸Å°³ ¼ö¼Û(ØÚË¿âÃáê)
  • oxygen transport
    »ê¼Ò¿î¹Ý(ß«áÈê¡Úæ)
  • passive mediated transport
    ¼öµ¿ ¸Å°³¿î¹Ý(áôÔÑØÚË¿ê¡Úæ)
  • passive transport
    ¼öµ¿ ¼ö¼Û(áôÔÑâÃáê)
  • photosynthetic electron transport
    ±¤ÇÕ¼º ÀüÀÚ ¼ö¼Û(ï³í­âÃáê)
  • post-translational transport
    ¹ø¿ªÈÄ ¿î¹Ý(ê¡Úæ)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • secondary active transport
    ÀÌÂ÷ ´Éµ¿¼ö¼Û(ì£ó­ÒöÔÑâÃáê)
  • transcellular transport
    ¸·È¾´Ü ¼ö¼Û(دüôÓ¨âÃáê)
  • transport
    ¼ö¼Û(âÃáê)
  • transport agent
    ¼ö¼ÛÁ¦(âÃáêð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVTR charcoal viral transport medium
EOT effective oxygen transport
ETC electron transport chain; esophageal tracheal combitude; estimated time of conception
ETP electron transport particle; entire treatment period; ephedrine, theophylline, phenobarbital; eustac...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCT Mucociliary transport
NTF2 Nuclear transport factor 2
PST Phosphate Specific Transport
RCT Reverse Cholesterol Transport
"Tm" Transport maximum
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
passive transport <biochemistry, physiology> The movement of a substance, usually across a plasma membrane, by a mechanism that does not require metabolic energy.
See: active transport, transport protein, facilitated diffusion, ion channels.
(18 Nov 1997)
renal tubular transport, inborn errors Genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of henle function, and distal nephron function. The transport defects can be selective or nonselective.
(12 Dec 1998)
respiratory transport The processes of gas exchange and various metabolic functions taking place in the lung, generally at the alveolar level.
(12 Dec 1998)
membrane transport <cell biology> The transfer of a substance from one side of a plasma membrane to the other, in a specific direction and at a rate faster than diffusion alone.
See: active transport.
(18 Nov 1997)
retrograde axonal transport <cell biology> The transport of vesicles from the synaptic region of an axon towards the cell body: involves the interaction of MAP1C with microtubules.
(11 Jan 1998)
channel transport <radiobiology> In inertial fusion research using light ion drivers, describes the use of current-carrying plasma channels (which are magnetically confined to the channel) to transport electron or ion beams between the ion diode and the fusion target. This allows the ion source to stand back from the target.
(09 Oct 1997)
reverse electron transport <chemistry> The energy-dependent movement of electrons against the thermodynamic gradient to form a strong reductant from a weaker electron donor.
(11 Jan 1998)
cholesterol ester transport proteins A protein that transports cholesterol esters from HDL to VLDL and LDL; a deficiency of this protein is associated with elevated HDL cholesterol.
(05 Mar 2000)
monosaccharide transport proteins Membrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium atpase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin b, and inhibitors of the sodium potassium atpase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell.
(12 Dec 1998)
cotranslational transport <cell biology> Process whereby a protein is moved across a membrane as it is being synthesised.
This process occurs during the translation of the message at membrane associated ribosomes in rough endoplasmic reticulum during the synthesis of secreted proteins in eukaryotic cells.
(18 Nov 1997)
coupled transport The linked, simultaneous transport of two substances across a cell membrane (or another intracellular membrane). If the two substances are moving in the same direction (both into the cell or both out of the cell) it is called symport. If the two substances are moving in opposite directions (one moves into the cell while the other moves out) it is called antiport.
(09 Oct 1997)
hydrogen transport The transfer of hydrogen from one metabolite (hydrogen donor) to another (hydrogen acceptor) through the action of an enzyme system; the donor is thus oxidised and the acceptor reduced.
(05 Mar 2000)
sperm transport Passive transport or active migration of spermatozoa from the testes through the male genital system as well as within the female genital system.
(12 Dec 1998)
nuclear transport <cell biology> Passage of molecules in and out of the nucleus, presumably via nuclear pores. Passage of proteins into the nucleus may depend on possession of a nuclear location sequence containing five consecutive positively charged residues PKKKRKV).
(18 Nov 1997)
nucleocytoplasmic transport <cell biology, molecular biology> Transport of molecules from the nucleus to the cytoplasm.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • collector's item (piece)
    ¼öÁý°¡ÀÇ Èï¹Ì¸¦ ²ô´Â ¹°°Ç;ÀÏǰ
  • companion piece
    (¹®ÇÐ ÀÛǰµîÀÇ)ÀÚ¸ÅÆí
  • conversation piece
    dz¼ÓÈ­;´Ü¶õµµ(18¼¼±â ¿µ±¹¿¡¼­ À¯ÇàÇÑ);È­Á¦°Å¸®°¡ µÇ´Â°Í(Áø±âÇÑ °¡±¸.ÀÇ·ù.Àå½Äǰµî)
  • costume piece (play)
    ½Ã´ë±Ø(½Ã´ë ÀÇ»óÀ» ÀÔ°í ÇÏ´Â)
  • crown piece
    Å©¶ó¿î ÀºÈ­
  • fancy piece
    ¾ÖÀÎ
  • flower piece
    ²É±×¸²
  • fourpenny piece
    4Ææ½º ÀºÈ­
  • museum piece
    ¹Ú¹°°üÀÇ Áø¿­Ç°;¹Ú¹°°ü Áø¿­°¨;ÁøÇ°
  • night piece
    ¾ß°æÈ­;¾ß°æÀ» ´Ù·é ÀÛǰ(ȸȭ,¾Ç°î)
  • party piece
    Àå±â;Ư±â
  • piece
    Á¶°¢;´ÜÆí;ÇÑ Á¶°¢;ºÎºÐǰ;ÇÑ ±¸È¹;ÇѰ³;ÇÑÀå;ÇÑ¿¹;(ÀÏÁ¤ÇÑ ºÒ·®À» ³ª´©¾î³»´Â)ÇÑ ÇÊ;ÇÑ Åë(µûÀ§);È­Æó;ÀÛǰÀÇ ÇÑ Æí;ÇÑ °î;ÃÑ;´ëÆ÷(Àå±âµîÀÇ)¸»-Á¢ÇÕÇÏ´Ù;ÀÕ´ë¾î¼­ ¼ö½ÃÇÏ´Ù(¸¸µé´Ù)
  • piece goods
    ÇÇ·ú 
  • pocket piece
    Çà¿îÀÇ µ¿Àü(ºÎÀûÀ¸·Î ÁÖ¸Ó´Ï¿¡ ³Ö°í ´Ù´Ï´Â µ·)
  • ridge-piece
    =RIDGEPOLE
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á